Skip to content

Effect of ingestion of yacon syrup in human

Metabolic benefits of nutraceuticals in human health

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-33wf46
Enrollment
Unknown
Registered
2018-03-12
Start date
2018-03-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appetite

Interventions

Treatment A: standard breakfast (180mL of milk 3% fat, 60mL of infusion coffee 5%, 10g of crystal sugar, 50g of french bread, 15g of butter, 32g of cheese, 100mL of water) and yacon syrup (40g of malt
Dietary supplement

Sponsors

Fundação Universidade Estadual do Ceará FUNECE
Lead Sponsor
Empresa Brasileira de Pesquisa Agropecuária
Collaborator

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Women; between 20 and 40 years old; do not present chronic self-reported diseases; have a body mass index of eutrophy or obesity grade I; regular menstrual cycle.

Exclusion criteria

Exclusion criteria: Pregnancy or lactation; hysterectomy performed; current smoker or in the last 30 days; users of illicit drugs; daily consumption of ethanol higher than 15g; current or last 30 days use of hypoglycemic, lipid-lowering, antibiotic and anti-inflammatory medications, laxatives or weight-loss medications; have inflammatory diseases such as inflammatory bowel disease (Crohn's disease, ulcerative colitis); endocrinopathy carrier’s (cushing's syndrome, hypothyroidism), cancer carrier’s, having celiac disease or lactose intolerance; have constipation history; present current consumption and in the last 30 days of fiber and fructooligosaccharides supplementation.

Design outcomes

Primary

MeasureTime frame
Improvement of the postprandial response of the plasma biomarkers of appetite after ingestion of yacon syrup compared to placebo;verified by blood dosage of glucagon-like peptide 1 (GLP1) and ghrelin at times 0, 15, 30, 45, 60, 90, 120 and 180. The improvement will be verified if there is statistical significance (p <0.05) in the comparison of the areas under the curve between treatment A (syrup intake) and treatment B (placebo intake), a difference of at least 50% between treatments is expected.

Secondary

MeasureTime frame
Improvement of the postprandial response of serum glycemia, serum insulin, serum triglycerides and subjective sensation of satiety after yacon syrup ingestion compared to placebo; verified by glucose, insulin and triglycerides blood dosages and self-reporting on satiety at times 0, 15, 30, 45, 60, 90, 120 and 180. The improvement will be verified if there is statistical significance (p <0, 05) in the comparison of the areas under the curve between treatment A (syrup intake) and treatment B (placebo intake), a difference of at least 50% between treatments is expected.

Countries

Brazil

Contacts

Public ContactLia Adriano

Fundação Universidade Estadual do Ceará FUNECE

liasilveira0404@gmail.com+55-085-31019601

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Mar 1, 2026